Sugi Predict

Sugi Predict / Compounds / SCHEMBL5565820

SCHEMBL5565820

SCHEMBL5565820

CC(N)CCNCCCCCCCCCCNCCCN

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.56
▸ CA2 P00918 3/20 0.56
▸ CA4 P22748 3/20 0.56
▸ CA6 P23280 3/20 0.56
▸ CA5A P35218 3/20 0.56
▸ CA7 P43166 3/20 0.56
▸ CA9 Q16790 3/20 0.56
▸ CA14 Q9ULX7 3/20 0.56
▸ CA5B Q9Y2D0 3/20 0.56
▸ F13A1 P00488 2/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ ALOX15 P16050 2/20 0.56
▸ THPO P40225 2/20 0.56
▸ CASP2 P42575 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ CA3 P07451 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6030318 1.00 CA12 (0.56) CA12CA2CA4CA6CA5A
SCHEMBL6030226 1.00 CA12 (0.56) CA12CA2CA4CA6CA5A
SCHEMBL343049 0.98 CA12 (0.59) CA12CA2CA4CA6CA5A
SCHEMBL14360554 0.98 CA12 (0.59) CA12CA2CA4CA6CA5A
SCHEMBL12227390 0.96 CA12 (0.54) CA12CA2CA4CA6CA5A
SCHEMBL14163247 0.96 CA12 (0.54) CA12CA2CA4CA6CA5A
SCHEMBL5196477 0.96 CA12 (0.55) CA12CA2CA4CA6CA5A
SCHEMBL14163238 0.93 CA12 (0.48) CA12CA2CA4CA6CA5A
SCHEMBL344818 0.93 CA12 (0.56) CA12CA2CA4CA6CA5A
SCHEMBL10045270 0.93 CA12 (0.52) CA12CA2CA4CA6CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3802850-B1 DEVICES AND SYSTEMS FOR GASTROINTESTINAL MICROBIOME DETECTION AND MANIPULATION BT BIDCO INC (US) 2025-11-19 — — EP disclosed
US-20250000364-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS GLAS USA LLC 2025-01-02 — — US disclosed
US-12089916-B2 Gastrointestinal tract detection methods, devices and systems BIORA THERAPEUTICS, INC. (US) 2024-09-17 — — US disclosed
CN-112400024-B Device and system for gastrointestinal microbiome detection and processing 比奥拉治疗股份有限公司 2024-04-09 — — CN disclosed
EP-4252629-A2 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS Biora Therapeutics, Inc. (US) 2023-10-04 — — EP disclosed
EP-3551046-B1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS BIORA THERAPEUTICS INC (US) 2023-07-19 — — EP disclosed
US-11547301-B2 Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract BIORA THERAPEUTICS, INC. (US) 2023-01-10 — — US disclosed
US-20210386367-A1 DEVICES AND SYSTEMS FOR GASTROINTESTINAL MICROBIOME DETECTION AND MANIPULATION GLAS USA LLC 2021-12-16 — — US disclosed
US-20210196127-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS GLAS USA LLC 2021-07-01 — — US disclosed
US-20200221954-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS GLAS USA LLC 2020-07-16 — — US disclosed
WO-2018106933-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS PROGENITY INC. (US) 2018-06-14 — — WO disclosed
WO-2018106931-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS PROGENITY INC. (US) 2018-06-14 — — WO disclosed
US-20180049725-A1 SYSTEMS AND METHODS FOR OBTAINING SAMPLES USING INGESTIBLE DEVICES PROGENITY, INC. 2018-02-22 — — US disclosed
US-20180052084-A1 SAMPLING SYSTEMS AND RELATED MATERIALS AND METHODS GLAS USA LLC 2018-02-22 — — US disclosed
EP-1623010-A4 PRESERVATION OF RNA IN A BIOLOGICAL SAMPLE JANSSEN PHARMACEUTICA NV (BE) 2007-12-26 — — EP disclosed
US-20060166258-A1 Preservation of RNA in a biological sample KAMME FREDRIK C 2006-07-27 — — US disclosed
US-7056673-B2 Preservation of RNA in a biological sample JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-06 — — US disclosed
EP-1623010-A2 PRESERVATION OF RNA IN A BIOLOGICAL SAMPLE JANSSEN PHARMACEUTICA N.V. (BE) 2006-02-08 — — EP disclosed
US-20040259133-A1 Preservation of RNA in a biological sample KAMME FREDRIK C (US) 2004-12-23 — — US disclosed
WO-2004096984-A2 PRESERVATION OF RNA IN A BIOLOGICAL SAMPLE JANSSEN PHARMACEUTICA N.V. (BE) 2004-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12089916-B2 Gastrointestinal tract detection methods, devices and systems FABP2, SI, MLNR CA12 188/4885CA2 1034/4885CA4 607/4885
US-20210196127-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS FABP2, SI, MLNR CA12 188/4885CA2 1034/4885CA4 607/4885
US-20200221954-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS FABP2, SI, MLNR CA12 188/4885CA2 1034/4885CA4 607/4885
US-11547301-B2 Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract SI, VIP, MLN CA12 2674/4885CA2 3083/4885CA4 1756/4885
US-20210386367-A1 DEVICES AND SYSTEMS FOR GASTROINTESTINAL MICROBIOME DETECTION AND MANIPULATION SI, MGAM, MLNR CA12 4844/4885CA2 4378/4885CA4 4071/4885
US-20250000364-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS FABP2, SI, MLNR CA12 188/4885CA2 1034/4885CA4 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.